bioAffinity Regains Nasdaq Compliance, Shares Surge
BIAF has more than doubled off its 52-week low of $4.56.
Summary
bioAffinity Technologies has regained compliance with Nasdaq listing requirements, resolving the delisting notice received on July 31 for failing the $1 minimum bid price rule. The stock is surging on the news. This follows a reverse split on August 24 and a $3.2 million offering in June, with the company still facing a going concern warning and a cash runway that ends this month. Regaining compliance removes a major overhang, but the company's financial position remains precarious.
At the time of this announcement, BIAF was trading at $10.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $4.56 to $202.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.